Organigram Holdings Inc. (TSE:OGI – Get Free Report) Director Donald Geoffrey Machum sold 17,929 shares of Organigram stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of C$1.86, for a total value of C$33,347.94. Following the transaction, the director owned 1,125 shares of the company’s stock, valued at C$2,092.50. The trade was a 94.10% decrease in their position.
Donald Geoffrey Machum also recently made the following trade(s):
- On Wednesday, March 25th, Donald Geoffrey Machum sold 10,700 shares of Organigram stock. The shares were sold at an average price of C$1.87, for a total value of C$20,009.00.
- On Wednesday, March 25th, Donald Geoffrey Machum sold 12,400 shares of Organigram stock. The shares were sold at an average price of C$1.87, for a total value of C$23,188.00.
- On Wednesday, March 25th, Donald Geoffrey Machum sold 10,471 shares of Organigram stock. The stock was sold at an average price of C$1.86, for a total value of C$19,476.06.
- On Wednesday, March 25th, Donald Geoffrey Machum sold 3,700 shares of Organigram stock. The stock was sold at an average price of C$1.87, for a total value of C$6,919.00.
- On Wednesday, March 25th, Donald Geoffrey Machum sold 17,347 shares of Organigram stock. The shares were sold at an average price of C$1.85, for a total value of C$32,091.95.
- On Wednesday, March 25th, Donald Geoffrey Machum sold 500 shares of Organigram stock. The shares were sold at an average price of C$1.87, for a total value of C$935.00.
- On Wednesday, March 25th, Donald Geoffrey Machum sold 600 shares of Organigram stock. The shares were sold at an average price of C$1.85, for a total value of C$1,110.00.
- On Thursday, March 26th, Donald Geoffrey Machum sold 700 shares of Organigram stock. The shares were sold at an average price of C$1.88, for a total transaction of C$1,316.00.
- On Thursday, March 26th, Donald Geoffrey Machum sold 100 shares of Organigram stock. The stock was sold at an average price of C$1.86, for a total transaction of C$186.00.
- On Thursday, March 26th, Donald Geoffrey Machum sold 400 shares of Organigram stock. The stock was sold at an average price of C$1.89, for a total transaction of C$756.00.
Organigram Stock Performance
OGI traded down C$0.07 on Monday, reaching C$1.74. The company had a trading volume of 74,982 shares, compared to its average volume of 233,742. The stock has a market cap of C$237.23 million, a P/E ratio of 11.30, a P/E/G ratio of 0.42 and a beta of 1.81. The company has a debt-to-equity ratio of 2.29, a quick ratio of 2.62 and a current ratio of 2.73. Organigram Holdings Inc. has a fifty-two week low of C$1.22 and a fifty-two week high of C$3.09. The company’s fifty day moving average is C$1.98 and its 200 day moving average is C$2.25.
Analyst Ratings Changes
Read Our Latest Stock Report on Organigram
Organigram News Roundup
Here are the key news stories impacting Organigram this week:
- Neutral Sentiment: Lower intraday liquidity and technicals: volume is below the stock’s average, and the share price sits under both the 50-day (C$1.98) and 200-day (C$2.25) moving averages, which can amplify downward moves.
- Neutral Sentiment: Company size and valuation context: market cap ≈ C$240M with a P/E ≈ 11.4 and PEG ≈ 0.42 — valuation metrics that may limit downside for some value-oriented buyers but are not a strong near-term demand driver.
- Negative Sentiment: Significant director selling disclosed (Mar 25–26): Director Donald Geoffrey Machum sold a total of approximately 76,647 OGI shares across multiple filings for roughly C$143k in proceeds, leaving him with 1,125 shares (substantially reduced ownership). Insider sales at scale often weigh on sentiment and can prompt short-term selling pressure. MarketBeat filings
Organigram Company Profile
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Read More
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.
